$QNRX
Quoin Pharmaceuticals Ltd.
Nasdaq · Healthcare · Pharmaceutical Preparations · Ashburn, VA
QNRX chart
What traders are saying about $QNRX
Latest postsQuoin Pharmaceuticals Ltd. news
- MAXONA PHARMACEUTICALS RECEIVES NOTICE OF ALLOWANCE FOR ITS PATENT APPLICATION RELATING TO THE USE OF NEFOPAM IN THE TREATMENT OF PRURITUS
Yahoo Finance ·
- Form 4 Quoin Pharmaceuticals Ltd DRC: Dennis Langer (Director) For: 27 August
Investing.com Nigeria ·
- Amendment: SEC Form 4/A filed by Quoin Pharmaceuticals Ltd.
Quantisnow ·
- A director’s corrected holdings total 49,687 depositary shares at Quoin Pharmaceuticals (QNRX).
Stock Titan ·
- Quoin Pharmaceuticals, Ltd. Estimates – NASDAQ:QNRX
TradingView ·
- Quoin Pharmaceuticals Announces Publication of Peer-Reviewed Paper on QRX003 for Netherton Syndrome in Dermatology and Therapy
Yahoo Finance ·
- Quoin Pharmaceuticals Announces European Medicines Agency (EMA) Grants Orphan Drug Designation for QRX003 for the Treatment of Peeling Skin Syndrome
Yahoo Finance ·
- Quoin Pharmaceuticals Announces Acceptance of QRX003 Paper in Dermatology and Therapy
Yahoo Finance ·
- Quoin Pharmaceuticals Announces FDA Fast Track Designation for QRX003 for the Treatment of Peeling Skin Syndrome
Yahoo Finance ·
- Quoin Pharmaceuticals Releases New NETHERTON NOW Video: Aminah’s Story Featuring Laura Wright-Sexton, MD, the Physician Who First Met Her Daughter in the ICU
Yahoo Finance ·
- CORRECTION -- Quoin Pharmaceuticals Announces FDA Grants Rare Pediatric Disease Designation for QRX003 in Peeling Skin Syndrome
Yahoo Finance ·
- Quoin in line for priority review voucher if rare paediatric drug approved
pharmaceutical-technology.com ·
Quoin Pharmaceuticals Ltd. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | – | – | – | – |
| Net income | -$15.8M | -$9.0M | -$8.7M | -$9.4M |
| Diluted EPS | – | – | – | – |
| Total assets (year end) | $20.4M | $15.7M | $12.2M | $14.5M |
| Cash and equivalents (year end) | $3.8M | $3.6M | $2.4M | $2.9M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Quoin Pharmaceuticals Ltd.
- Ticker
- QNRX (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Ashburn, VA
- Incorporated in
- Israel
- SEC CIK
- 1671502
- Former names
- Quoin Pharmaceuticals, Ltd., Cellect Biotechnology Ltd., Cellect Biomed Ltd.
Frequently asked questions
What exchange is Quoin Pharmaceuticals Ltd. listed on?
Quoin Pharmaceuticals Ltd. trades on the Nasdaq under the ticker symbol QNRX.
What industry is Quoin Pharmaceuticals Ltd. in?
Quoin Pharmaceuticals Ltd. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Quoin Pharmaceuticals Ltd. headquartered?
Quoin Pharmaceuticals Ltd.'s business address on file with the SEC is in Ashburn, VA.
How much revenue did Quoin Pharmaceuticals Ltd. report?
Quoin Pharmaceuticals Ltd. reported $0 in revenue for calendar year 2021, according to its SEC filings.